Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Cross-border Movement of Hazardous Waste and Hazardous Recyclable Material Regulations (SOR/2021-25)

Regulations are current to 2022-07-25 and last amended on 2021-10-31. Previous Versions

SCHEDULE 6(Paragraphs 2(1)(a), 4(1)(a), 14(1)(e) and 26(1)(f), clause 78(1)(a)(iii)(I) and Schedules 3 and 4)

Hazardous Waste and Hazardous Recyclable Material

Column 1Column 2
ItemCodeDescription of Hazardous Waste and Hazardous Recyclable Material
1HAZ1
  • (1) Biomedical waste — the following waste, other than that set out in subitem (2) or that generated from building maintenance, office administration or food preparation and consumption, that is generated by human or animal health care establishments, medical, health care or veterinary teaching or research establishments, clinical laboratories or facilities that test or produce vaccines, and needle and syringe exchange programs:

    • (a) human tissues, organs or body parts, excluding teeth, hair or nails;

    • (b) human blood or blood products;

    • (c) human bodily fluids that are contaminated with blood;

    • (d) human bodily fluids that are removed in the course of autopsy, treatment, or surgery for diagnosis;

    • (e) animal tissues, organs, body parts or carcasses, excluding teeth, nails, hair, bristles, feathers, horns and hooves, that result from the treatment of an animal for contamination or suspected contamination with an infectious substance that meets the criteria for inclusion in Class 6.2 as set out in Part 2 of the Transportation of Dangerous Goods Regulations;

    • (f) animal blood or blood products that result from the treatment of an animal for contamination or suspected contamination with an infectious substance that meets the criteria for inclusion in Class 6.2 as set out in Part 2 of the Transportation of Dangerous Goods Regulations;

    • (g) animal bodily fluids that are visibly contaminated with animal blood and that result from the treatment of an animal for contamination or suspected contamination with an infectious substance that meets the criteria for inclusion in Class 6.2 as set out in Part 2 of the Transportation of Dangerous Goods Regulations;

    • (h) animal bodily fluids that are removed in the course of surgery, treatment or necropsy, and that result from the treatment of an animal for contamination or suspected contamination with an infectious substance that meets the criteria for inclusion in Class 6.2 as set out in Part 2 of the Transportation of Dangerous Goods Regulations;

    • (i) live or attenuated vaccines, human or animal cell cultures, microbiology laboratory cultures, stocks or specimens of microorganisms and any items that have come into contact with them;

    • (j) any items that are saturated with the blood or bodily fluids referred to in paragraphs (b) to (d) or (f) to (h), including items that were saturated but have dried; and

    • (k) cytotoxic drugs and any items, including tissues, tubing, needles or gloves, that have come into contact with a cytotoxic drug.

  • (2) Biomedical waste does not include the following:

    • (a) urine or feces;

    • (b) waste that is controlled under the Health of Animals Act; or

    • (c) waste that results from the breeding or raising of animals.

2HAZ2Used lubricating oils in quantities of 500 L or more, from internal combustion engines or gear boxes, transmissions, transformers, hydraulic systems or other equipment associated with such engines.
3HAZ3Used oil filters containing more than 6% of oil by mass.
4HAZ4Cyanide, or substances containing cyanide, in a concentration equal to or greater than 100 mg/kg.
5HAZ5Waste that contains more than 2 mg/kg of polychlorinated terphenyls or polybrominated biphenyls as those substances are described in Schedule 1 to the Act.
6HAZ6
  • (1) Waste that contains, in a concentration of more than 100 ng/kg of 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalent, calculated in accordance with subitem (2),

    • (a) total polychlorinated dibenzofurans that have a molecular formula C12H8-nClnO in which “n” is greater than 1; or

    • (b) total polychlorinated dibenzo-p-dioxins that have a molecular formula C12H8-nClnO2 in which “n” is greater than 1.

  • (2) The concentration is calculated in accordance with “International Toxicity Equivalency Factor (I-TEF) Method of Risk Assessment for Complex Mixtures of Dioxins and Related Compounds”, Pilot Study on International Information Exchange on Dioxins and Related Compounds, Committee on the Challenges of Modern Society, North Atlantic Treaty Organization, Report Number 176, August 1988, as amended from time to time, using the following factors:

    • (a) 2,3,7,8-tetrachlorodibenzodioxinblank line1.0

    • (b) 1,2,3,7,8-pentachlorodibenzodioxinblank line0.5

    • (c) 1,2,3,4,7,8-hexachlorodibenzodioxinblank line0.1

    • (d) 1,2,3,7,8,9-hexachlorodibenzodioxinblank line0.1

    • (e) 1,2,3,6,7,8-hexachlorodibenzodioxinblank line0.1

    • (f) 1,2,3,4,6,7,8-heptachlorodibenzodioxinblank line0.01

    • (g) octachlorodibenzodioxinblank line0.001

    • (h) 2,3,7,8-tetrachlorodibenzofuranblank line0.1

    • (i) 2,3,4,7,8-pentachlorodibenzofuranblank line0.5

    • (j) 1,2,3,7,8-pentachlorodibenzofuranblank line0.05

    • (k) 1,2,3,4,7,8-hexachlorodibenzofuranblank line0.1

    • (l) 1,2,3,7,8,9-hexachlorodibenzofuranblank line0.1

    • (m) 1,2,3,6,7,8-hexachlorodibenzofuranblank line0.1

    • (n) 2,3,4,6,7,8-hexachlorodibenzofuranblank line0.1

    • (o) 1,2,3,4,6,7,8-heptachlorodibenzofuranblank line0.01

    • (p) 1,2,3,4,7,8,9-heptachlorodibenzofuranblank line0.01

    • (q) octachlorodibenzofuranblank line0.001

7HAZ7Circuit boards and display devices and any equipment that contains them.
8HAZ8Non-rechargeable and rechargeable cells and batteries.
 
Date modified: